US FDA approves Zevra's genetic disorder treatment

Zevra Therapeutics

20/09/2024 15:09

Sept 20 (Reuters) - The U.S. Food and Drug
Administration approved Zevra Therapeutics'  ZVRA.O  drug for a
rare and fatal genetic disorder, the first treatment to get a
nod for the condition, the health regulator said on Friday.

 (Reporting by Sriparna Roy and Kashish Tandon in Bengaluru;
Editing by Devika Syamnath)
 ((Kashish.Tandon@thomsonreuters.com; 8800437922;))